Event overview

Oncology is unique within pharma.  It’s the fastest growing area, but if you are preparing products for a successful launch or involved in marketing existing therapies or dealing with payors then you face an increasingly crowded market place.

The oncology environment is changing quickly and you must adapt fast and justify your decisions to make the most of the opportunities.

This conference brings together oncology medical directors with business unit heads and marketing directors.  Those involved with launching and marketing Oncology will discover answers to the most pressing issues from pricing to strategy and market access to marketing to different stakeholders.

Hope to see you in Zurich.

Click Here to register your place today

The conference will enable you to:

• Understand how budget holders and healthcare systems view value and what makes a payer reject a drug for approval
• Understand the impact of innovative pricing and access structures for oncology: efficacy guarantees; risk-sharing with payers; price caps
• Understand the models, opportunities, risks and value of Phase IV strategies in oncology to reduce risk in market access
• Beyond QALY: learn how to prove value to the most demanding of reimbursement agencies
• Learn how to develop insight into payers, KOLs and budget managers to unify into a compelling proposition for prescribers
• Find out how the oncology environment will change by 2020 and how to adapt to a competitive oncology marketplace

Find out more on the PDF brochure

Speaker lineup

	Niko Andre, International Medical Leader, Roche		Robert Day, Head of the Oncology Business Unit, UK, Pfizer
	Andrea Bracco, International Director of Market Access, Amgen		Yasmina Eroglu, Head of Marketing oncology, EEMEA, Novartis
	Christopher Teale, Global Director Pricing & Market Access, AstraZeneca		Jeroen van Dijk, Director of Oncology, Roche Nederland
	Ulf Staginnus, Head Pricing, Health Economics and Outcome Research Europe, Novartis		Boyka Stoykova, Health Economist, Wyeth
	Uday Bose, European Marketing Director, gsk		Jerome Moreau, Business Unit Director - Oncology, Cephalon
	David Perry, VP Global Clinical & Medical Affairs, Baxter		Eckart Knipping, International Marketing Director Oncology, GE Healthcare